Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/99765
COMPARTIR / EXPORTAR:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Invitar a revisión por pares abierta
Campo DC Valor Lengua/Idioma
dc.contributor.authorCastro, Sonia de-
dc.contributor.authorCamarasa Rius, María José-
dc.contributor.authorBalzarini, Jan-
dc.contributor.authorVelázquez, Sonsoles-
dc.date.issued2014-
dc.identifierdoi: 10.1016/j.ejmech.2014.06.026-
dc.identifierissn: 0223-5234-
dc.identifiere-issn: 1768-3254-
dc.identifier.citationEuropean Journal of Medicinal Chemistry 83: 174- 189 (2014)-
dc.identifier.urihttp://hdl.handle.net/10261/99765-
dc.description.abstractHerein we report a novel class of 1,4-disubstituted piperidines as potential anticancer agents. One-step and efficient synthesis of a structurally diverse library of piperidine-based analogs with five points of diversity has been developed using the Ugi four-component reaction. A structure-activity relationship (SAR) study showed that the presence of a benzyl or a Boc group at the N-1 position together with two or three aromatic groups at the C-4 position of the piperidine ring are important for optimal cytostatic properties. Compounds 20, 22, 27 and 29 were found to be the most potent with a 50% inhibitory concentration (IC50) ranging between 3 and 9.5 μM in the cancer cell lines evaluated. The NCI60 screen confirmed this 50% cytostatic concentration range for compound 20, irrespective of the nature of the tumor cell lines evaluated. The NCI COMPARE algorithm did not show any significant correlation between the growth inhibition profile of compound 20 with the NCI database compound profiles suggesting a potential novel mechanism of action.-
dc.description.sponsorshipThe authors thank Mrs. Lizette van Berckelaer and Mrs. Kristien Minner for excellent technical assistance in the cytostatic evaluations. We also thank the Spanish MINECO (Project SAF2012- 39760-C02), the Comunidad de Madrid (BIPEDD-2-CM ref S-2010/ BMD-2457) and the KU Leuven (GOA 10/014) for fi nancial support. We also give thanks to the Spanish Ministry of Science and Inno- vation for a Juan de la Cierva contract to S.d.C. (JDC-MICINN). The National Institutes of Health (NIH) is gratefully acknowledged for their willingness to include compound 20 in their NCI60 anticancer screen-
dc.publisherElsevier-
dc.rightsclosedAccess-
dc.subjectDisubstituted piperidines-
dc.subjectUgi reaction-
dc.subjectAnticancer-
dc.subjectStructureeactivity relationships-
dc.titleDiscovery and SAR studies of a novel class of cytotoxic 1,4-disubstituted piperidines via Ugi reaction-
dc.typeartículo-
dc.identifier.doi10.1016/j.ejmech.2014.06.026-
dc.relation.publisherversionhttp://dx.doi.org/10.1016/j.ejmech.2014.06.026-
dc.date.updated2014-07-14T09:13:56Z-
dc.description.versionPeer Reviewed-
dc.language.rfc3066eng-
dc.contributor.funderMinisterio de Economía y Competitividad (España)-
dc.contributor.funderMinisterio de Ciencia e Innovación (España)-
dc.contributor.funderComunidad de Madrid-
dc.contributor.funderUniversity of Leuven-
dc.identifier.funderhttp://dx.doi.org/10.13039/501100003329es_ES
dc.identifier.funderhttp://dx.doi.org/10.13039/501100004837es_ES
dc.identifier.funderhttp://dx.doi.org/10.13039/100012818es_ES
dc.type.coarhttp://purl.org/coar/resource_type/c_6501es_ES
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
item.openairetypeartículo-
item.fulltextNo Fulltext-
Aparece en las colecciones: (IQM) Artículos
Show simple item record

CORE Recommender

SCOPUSTM   
Citations

9
checked on 03-may-2024

WEB OF SCIENCETM
Citations

8
checked on 27-feb-2024

Page view(s)

341
checked on 03-may-2024

Google ScholarTM

Check

Altmetric

Altmetric


NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.